Skip to content

Bristol-Myers Squibb Company: interest expense

Bristol-Myers Squibb Company interest expense: $1.17 billion for the year ending 2023-12-31, down 5.4% on the year. 16 values since 2008 from SEC filings.

All Bristol-Myers Squibb Company financial histories

At a glance

Bristol-Myers Squibb Company reported interest expense of $1.17 billion for the year ending 2023-12-31, down 5.4% from $1.23 billion a year earlier. From 2008 to 2023 it grew at a compound 9.2% a year, from $310.0 million to $1.17 billion. Across the last five reported years it ranged from $656.0 million (2019-12-31) to $1.42 billion (2020-12-31). That was 2.6% of revenue ($45.0 billion) for the same year.

Computed from the values in the table below, in USD; each links to the filing it came from.

What this measure means

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Exact concept: us-gaap:InterestExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2008-01-01 to 2023-12-31. The SEC response was captured on 2026-09-19.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Interest expense in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
2023-01-012023-12-311,166,000,000USD2024-02-1310-K · 0000014272-24-000044 SEC
2022-01-012022-12-311,232,000,000USD2024-02-1310-K · 0000014272-24-000044 SEC
2021-01-012021-12-311,334,000,000USD2024-02-1310-K · 0000014272-24-000044 SEC
2020-01-012020-12-311,420,000,000USD2023-02-1410-K · 0000014272-23-000046 SEC
2019-01-012019-12-31656,000,000USD2022-02-0910-K · 0000014272-22-000051 SEC
2018-01-012018-12-31183,000,000USD2021-02-1010-K · 0000014272-21-000066 SEC
2017-01-012017-12-31196,000,000USD2020-02-2410-K · 0000014272-20-000082 SEC
2016-01-012016-12-31167,000,000USD2019-02-2510-K · 0000014272-19-000047 SEC
2015-01-012015-12-31184,000,000USD2018-02-1310-K · 0000014272-18-000055 SEC
2014-01-012014-12-31203,000,000USD2017-02-2110-K · 0000014272-17-000047 SEC
2013-01-012013-12-31199,000,000USD2016-02-1210-K · 0000014272-16-000288 SEC
2012-01-012012-12-31182,000,000USD2015-02-1310-K · 0000014272-15-000055 SEC
2011-01-012011-12-31145,000,000USD2014-02-1410-K · 0000014272-14-000054 SEC
2010-01-012010-12-31145,000,000USD2013-02-1510-K · 0001193125-13-061678 SEC
2009-01-012009-12-31184,000,000USD2012-02-1710-K · 0001193125-12-066416 SEC
2008-01-012008-12-31310,000,000USD2011-02-1810-K · 0001193125-11-040120 SEC

Related BRISTOL-MYERS SQUIBB COMPANY histories

All 61 Bristol-Myers Squibb Company histories

Inspect the source

Entity
BRISTOL-MYERS SQUIBB COMPANY / CIK 0000014272
Captured
SEC response SHA-256
a18ba88ed8f92b7f0cbc4d83a6db14b8fba95a5721f7f83a6306ca843ad40c2f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000014272.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))